Staff
Kazuhiro WatanabePh.D.Professor / Ph.D.last update : 2024.10.12
Profile
- Name
- Kazuhiro WatanabePh.D.
- Affiliation
- Center for Education & Research on Clinical Pharmacy
- Subjects
- Evaluation of Clinical Research
Information for Drug Therapy
Pre-training for Pharmacy Practice
Clinical pharmacy, like medicine and nursing, is a discipline directly related to clinical practice or patient care. The excitement of clinical pharmacy is learning about things directly related to human life and death, but it also comes with a great deal of responsibility. A good pharmacist is a medical professional who puts the patient first. People are naive about themselves. But if we cannot let go of this naivety, we cannot be called true medical professionals or pharmacists. I want you to become a pharmacist who is adored by patients and sought after by society. - Official title
- Professor
- Degree
- Ph.D.
Academic background
2017/04- Present Professor, Showa Pharmaceutical University, Center for Clinical Pharmaceutical Education and Research, Department of Practical Pharmaceutical Science, Division of Clinical Pharmaceutical Science
2013/04-2017/03 Associate Professor, Center for Clinical Pharmacy Education and Research, Showa Pharmaceutical University
2009/04-2013/03 Lecturer, Center for Education and Research in Medical Pharmacy, Showa Pharmaceutical University
1997/04-2009/03 Department of Pharmacy, St. Luke's International Hospital
Career history
2005 - 2008 Graduate School of Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Doctoral Program (Sociologist Program)
1995 - 1997 Graduate School of Pharmaceutical Sciences, Showa University of Pharmaceutical Sciences, Bachelor's Degree Program
1991 - 1995 Showa University of Pharmaceutical Sciences, Faculty of Pharmacy
Honors & Awards
2017/05 The Pharmaceutical Society of Japan, Asahi Kasei Creation Research Incentive Award
2016/06 Eguchi Memorial Cancer Outstanding Activity Award, Japan Hospital Pharmaceutical Association, 2016
Papers
- Original paper Adaptation of the European-Commission-recommended user testing method to patient medication information leaflets in Japan Yamamoto M, Doi H, Yamamoto K, Watanabe K, Sato T, Machi S, Nakayama T, Sugimori H Journal of Drug, Healthcare and Patient Safety 9 39-63
- Original paper Adaptation of the European-Commission-recommended user testing method to patient medication information leaflets in Japan" "Michiko Yamamoto, Hirohisa Doi, Ken Yamamoto, Kazuhiro Watanabe, Tsugumichi Sato, Suka Machi, Takeo Nakayama, Hiroki Sugimori" "Journal of Drug, Healthcare and Patient Safety" 9 39-63 2017
- [Original paper] Safe and Effective Deodorization of Malodorous Fungating Tumors Using Topical Metronidazole 0.75% Gel (GK567): A Multicenter, Open-Label, Phase III Study (RDT.07.SRE.27013) Watanabe K, Shimo A, Tsugawa K, Tokuda Y, Yamauchi H, Miyai E, Takemura K, Ikoma A, Nakamura S Supportive Care in Cancer 24 2583-2590 2016
- [Original paper] Validity of Recommended Dosage Reduction Criteria for Rivaroxaban in Patients with Renal Impairment Watanabe K, Terashi Y, Ishida K, Uematsu K, Endo I, Suzuki K, Suzuki I, Taguchi K Showa Pharmaceutical University. Bulletin of Showa Pharmaceutical University 49 1‐8 2015
- [Original paper] Hands-on Experiential Training of Self-Monitoring of Blood Glucose And Self-Injection of Insulin, And Its Learning Effects in 4th year Pharmacy Students Watanabe K, Doi H, Hirohara M, Ota A, Nakamura M, Kushida K, Takada K, Masuda Y, Kitajima, J, Takano A, Chiba R, Toda J, Hagiwara Y, Hamashima H, Hamamoto T, Fukumori R, Horiguchi Y, Yamamoto M, Taguchi K Journal of Drug Interaction Research 39 17-23 2015
Conference, etc.
- [Oral presentation] がん性皮膚潰瘍臭改善薬メトロニダゾールゲルと他剤との混合時における物性変化 渡部一宏、橋崎要、松村健太郎、藤井まき子 第136回日本薬学会年会 横浜 2016/03/26?2016/03/29
- [Special lecture/Symposium] 薬剤師視線での臨床研究の必要性とその成果?がん性皮膚潰瘍臭改善治療薬メトロニダゾールゲルの承認までのアプローチを経験して 渡部一宏 日本臨床腫瘍薬学会2016 鹿児島 2016/03/12?2016/03/13
- [Oral presentation] Topical metronidazole 0.75% gel for the safe and effective deodorization of malodorous fungating tumours: A multicentre, open-label, phase III study Delphine Kerob, Seigo Nakamura, Arata Shimo, Kouichiro Tsugawa, Yutaka Tokuda, Hideko Yamauchi, Kazuhiro Watanabe, Eriko Miyai, Kimitoshi Takemura, Akihiko Ikoma. The 2015 International MASCC/ISOO Symposium Copenhagen, Denmark 2015/01